Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
about
Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial.High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).How we diagnose and treat vitreoretinal lymphoma.Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature.Long-term survivors of primary central nervous system lymphoma.The Challenge of Primary Central Nervous System Lymphoma.Primary central nervous system lymphoma: essential points in diagnosis and management.Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.Efficacy and safety of HD-MTX based systemic chemotherapy regimens: retrospective study of induction therapy for primary central nervous system lymphoma in Chinese.The Elderly Left Behind - Changes in Survival Trends of Primary Central Nervous System Lymphoma Over The Past Four Decades.Diagnosis and management of primary central nervous system lymphoma.Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.Primary CNS Lymphoma.The challenge of adequate imaging surveillance in primary central nervous system lymphoma.Application value of CT and MRI in diagnosis of primary brain lymphoma.The Diagnosis and Treatment of Primary CNS LymphomaPrimary central nervous system lymphomaResponse-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy
P2860
Q31150088-955A301D-516F-4177-B86C-0782C93B50D4Q38795502-5204F322-5849-4CDA-A4CD-681079427F1BQ38822438-29535200-6991-41B9-8132-237560D196D4Q38926305-67ECED06-3414-43BD-9478-CB3BEF9EC170Q38973104-95A08A69-D06A-488F-B1EC-A159FDF7BBA5Q39020652-E67A2384-EAEB-4C23-92CF-ADDB3819E04BQ39185721-107A7F33-029F-4155-8EC6-9A746F26449DQ40071391-67FF73DB-14E3-40F6-A62E-F770084BA326Q47136050-A13902F6-5129-4761-ABDA-1AFC903007E1Q48016610-FD7EE46E-B969-4450-A890-7642B500C076Q48095976-3901058A-50FE-4316-80E2-2CA6CB36FE17Q48246102-DE41D11F-EC65-481D-8C56-6EEAED72187AQ51841565-890465B3-D26D-4E7C-9213-052045DE5FDCQ52843442-EE7F18E4-0002-4180-BB2A-0A231D53C3BEQ55332020-B41E3B19-F313-4B61-9E9C-CEA0E66DFB49Q56967801-B2E5B724-051D-4342-91CE-C09B5C342D69Q57297768-6D464707-C3BD-4FAC-BC73-D9CCF1794B2EQ58130542-C4F4F377-7C0C-45FE-8E27-62E0D6BD5401
P2860
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Methotrexate and temozolomide ...... LAMS randomised phase 2 trial.
@en
type
label
Methotrexate and temozolomide ...... LAMS randomised phase 2 trial.
@en
prefLabel
Methotrexate and temozolomide ...... LAMS randomised phase 2 trial.
@en
P2093
P50
P1476
Methotrexate and temozolomide ...... ELAMS randomised phase 2 trial
@en
P2093
Alberto Gonzalez-Aguilar
Alexandra Benouaich-Amiel
Antonio Omuro
Aymeri Huchet
Carole Soussain
Caroline Houillier
Daniel Delgadillo
Hervé Ghesquieres
Khê Hoang-Xuan
Luc Taillandier
P304
P356
10.1016/S2352-3026(15)00074-5
P577
2015-06-03T00:00:00Z